Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Breath-Enhanced and T-Piece Nebulizers in Children With Acute Asthma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age ≥ 6 years and \< 18 years~* History of physician diagnosed asthma~* Presenting to ED with breathing difficulty or cough~* Initial FEV1 25%-70% predicted~* Parent or guardian speaks English or Spanish.~Exclusion Criteria:~* Pediatric Asthma Score of 0~* Pregnancy or breast-feeding~* Immediate resuscitation required~* Chronic lung disease (other than asthma)~* Congenital heart disease~* Neuromuscular disease~* Suspected intrathoracic foreign body~* Allergy or other contraindication to study medication

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- T-piece Nebulizer (Type: ACTIVE_COMPARATOR): Pre-treatment spirometry measurement will be performed, intervention with a one time 5mg nebulized albuterol treatment will be administered with the experimental T-piece Nebulizer (Hudson RCI® Micro Mist® nebulizer Teleflex Medical®, Research Triangle Park, NJ). Treatment will be administered over 10 minutes. Following this therapy, post-treatment spirometry measurement will be performed.
- Breath-Enhanced Nebulizer (Type: EXPERIMENTAL): Pre-treatment spirometry measurement will be performed, intervention with a one time 5mg nebulized albuterol treatment will be administered with the experimental Breath-Enhanced Nebulizer (NebuTech® HDN®, Breath-Enhanced High Density Jet Nebulizer Salter Labs®, Arvin, CA). Treatment will be administered over 10 minutes. Following this therapy, post-treatment spirometry measurement will be performed.

Based on this trial design, predict the completion outcome and termination type (if applicable).